BioXcel Therapeutics Inc (NASDAQ: BTAI) on Friday, plunged -5.46% from the previous trading day, before settling in for the closing price of $1.83. Within the past 52 weeks, BTAI’s price has moved between $1.17 and $9.26.
Healthcare Sector giant saw their annual sales surged by 6.20% over the last five years. The company achieved an average annual earnings per share of 72.31%. With a float of $21.02 million, this company’s outstanding shares have now reached $21.87 million.
BioXcel Therapeutics Inc (BTAI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of BioXcel Therapeutics Inc is 3.89%, while institutional ownership is 10.78%.
BioXcel Therapeutics Inc (BTAI) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -3.56 earnings per share (EPS) for the period topping the consensus outlook (set at -5.14) by 1.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.37% during the next five years compared to 6.20% growth over the previous five years of trading.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Trading Performance Indicators
BioXcel Therapeutics Inc (BTAI) is currently performing well based on its current performance indicators. A quick ratio of 1.16 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 50.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.70, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of BioXcel Therapeutics Inc (BTAI)
Analysing the last 5-days average volume posted by the [BioXcel Therapeutics Inc, BTAI], we can find that recorded value of 0.46 million was lower than the volume posted last year of 3.95 million. As of the previous 9 days, the stock’s Stochastic %D was 6.74%.
During the past 100 days, BioXcel Therapeutics Inc’s (BTAI) raw stochastic average was set at 6.34%, which indicates a significant increase from 5.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1534 in the past 14 days, which was lower than the 0.3988 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0452, while its 200-day Moving Average is $2.3259. Now, the first resistance to watch is $1.8433. This is followed by the second major resistance level at $1.9567. The third major resistance level sits at $2.0283. If the price goes on to break the first support level at $1.6583, it is likely to go to the next support level at $1.5867. Now, if the price goes above the second support level, the third support stands at $1.4733.
BioXcel Therapeutics Inc (NASDAQ: BTAI) Key Stats
Market capitalization of the company is 37.83 million based on 21,869K outstanding shares. Right now, sales total 2,270 K and income totals -59,600 K. The company made 100 K in profit during its latest quarter, and -30,910 K in sales during its previous quarter.
